Skip to main content

Advertisement

Table 1 Baseline characteristics of a cohort from general population in Xiamen

From: Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

Group n (%) HSV-1 seroprevalence (%) HSV-1 NAb prevalence (%) Average NAb titers (log2NT50)
Age (years)    
≤10 41 (15.2 %) 29.3 % (17.6 %-44.5 %)* 31.7 % (19.6 %-47.0 %)* 4.4 ± 3.1
11-20 47 (17.5 %) 74.5 % (60.5 %-84.8 %)* 74.5 % (60.5 %-84.8 %)* 7.5 ± 3.1
21-30 41 (15.2 %) 92.7 % (80.6 %-97.5 %) 95.1 % (83.9 %-98.7 %) 9.2 ± 1.6
31-40 49 (18.2 %) 91.8 % (80.8 %-96.8 %) 97.9 % (89.3 %-99.6 %) 9.1 ± 1.4
41-50 48 (17.8 %) 91.7 % (80.5 %-96.87 %) 97.9 % (89.1 %-99.6 %) 9.5 ± 1.7
>50 43 (16.0) 97.7 % (87.9 %-99.6 %) 100 % (91.8 %-100 %) 9.8 ± 1.6
Gender     
Male 126 (46.8 %) 83.3 % (75.9 %-88.8 %) 84.9 % (77.7 %-90.1 %) 8.2 ± 2.8
Female 143 (53.2 %) 76.9 % (69.4 %-83.1 %) 82.5 % (75.5 %-87.9 %) 8.4 ± 2.9
Total 269 79.9 % (74.7 %-84.3 %) 83.6 % (78.8 %-87.6 %) 8.3 ± 2.8
  1. *p < 0.05; 95 % confidence interval shown in brackets